You are here: Industry Insights > granules

News List

Granules Pharmaceuticals clears US FDA audit expresspharma
July 23, 2021
The company had undergone the PAI audit by the US Food and Drug Administration (FDA) from 21st June, 2021 to 25th June, 2021.
Granules pledges 16 crore Paracetamol tablets to Telangana government to fight COVID-19 expresspharma
May 14, 2021
The company will provide one crore tablets every week, starting from today 12th May 2021, aggregating to 16 crore tablets worth Rs 8 crores over next four months.
Granules India gets USFDA approval for OTC Acetaminophen, Aspirin and Caffeine Tablets expresspharma
February 25, 2021
Granules India announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine Tablets USP, 250 mg/250 mg/65 mg (OTC).
Granules India gets US FDA approval for Potassium Chloride ER Capsules expresspharma
February 18, 2021
Potassium Chloride is indicated for the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis.
Granules India gets US FDA nod for Potassium Chloride Oral Solution expresspharma
February 02, 2021
Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis.
Granules India gets USFDA approval of Metformin Hydrochloride ER Tablets expresspharma
January 14, 2021
Metformin Hydrochloride ER Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Granules gets USFDA nod for ADHD drug dexmethylphenidate HCl extended-release capsules expresspharma
September 23, 2020
The drug will be manufactured at the Granules manufacturing facility in Chantilly, Virginia.
Granules Issues Recall of Metformin Hydrochloride Extended-Release Tablets americanpharmaceuticalreview
July 21, 2020
Granules Pharmaceuticals is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of NNitrosodimethylamine (NDMA) ...
Granules India gets EIR for Telangana facility financialexpress
May 21, 2018
Granules India announced that the US health regulator has issued the Establishment Inspection Report (EIR) after completing the audit of its Telangana facility.
Granules India posts Q2 net profit at Rs 40 crore expressbpd
November 10, 2017
Granules India has reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current fiscal.

Previous page 1 2 Next page